Spots Global Cancer Trial Database for Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Official Title: A Post-authorization, Observational Study to Assess the Impact of Blue Light Cystoscopy After Administration of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer.
Study ID: NCT00634621
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the effectiveness of hexaminolevulinate (Hexvix) in the diagnosis and treatment of patients with non-invasive bladder cancer and if it results in a change in patient management.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GE Healthcare, Madrid, , Spain
Contact Details
Name: Dr. Carlos Hernández
Affiliation: Gregorio Marañón Hospital, Madrid
Role: PRINCIPAL_INVESTIGATOR
Name: Dr. Eduardo Solsona
Affiliation: Valencian Institute of Oncology, Valencia
Role: PRINCIPAL_INVESTIGATOR
Name: Dr. Joan Palou
Affiliation: Fundación Puigvert, Barcelona
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
